Drug interaction analysis

SS Sarah Schott
PW Pauline Wimberger
BK Barbara Klink
KG Konrad Grützmann
JP Julian Puppe
UW Ulrike Sophie Wauer
DK Daniel Martin Klotz
ES Evelin Schröck
JK Jan Dominik Kuhlmann
request Request a Protocol
ask Ask a question
Favorite

Drug interaction analysis between 5-FdU-ECyd and cisplatin was based on cell viability data, obtained by the fluorometric Cell Titer Blue®-Assay (Promega, Fitchburg, USA), according to the manufacturer's instructions. Statistical analysis was performed by the combination index method [43], which is based on the combination of drugs at a broad range of equipotent molar concentrations or, as our modification, with standard cisplatin dose-response curves with a fixed 5-FdU-ECyd concentrations at each reading point. Additional information to this method is provided in Supplementary Materials.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A